Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9500 USD | -4.04% |
|
+1.60% | -68.33% |
May. 15 | CbdMD, Inc., Q2 2025 Earnings Call, May 15, 2025 | |
May. 15 | CbdMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 | CI |
Projected Income Statement: cbdMD, Inc.
Annual
Quarterly
Annual
Quarterly
Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 41.88 | 44.48 | - | 24.16 | 19.48 | 21.58 | 23.74 |
Change | - | 6.2% | - | - | -19.35% | 10.78% | 10% |
EBITDA | -16.86 | -18.6 | - | - | - | - | - |
Change | - | -10.3% | - | - | - | - | - |
EBIT 1 | -17.58 | -19.62 | - | -5.527 | -1.592 | -0.799 | -0.831 |
Change | - | -11.57% | - | - | 71.19% | 49.82% | -4.01% |
Interest Paid | 0.0399 | -0.0289 | - | - | - | - | - |
Earnings before Tax (EBT) 1 | 11.31 | -24.29 | - | -22.94 | -3.7 | -0.799 | -0.831 |
Change | - | -314.84% | - | - | 83.87% | 78.41% | -4.01% |
Net income 1 | 12.24 | -25.95 | -70.08 | -26.94 | -7.704 | -2.8 | -0.831 |
Change | - | -312.09% | -170.08% | 61.56% | 71.4% | 63.66% | 70.32% |
Announcement Date | 12/22/20 | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: cbdMD, Inc.
Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | -14.5 | -26.2 | - | - | - | - | - |
Change | - | -80.69% | - | - | - | - | - |
Announcement Date | 12/22/20 | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | - | - |
Estimates
Cash Flow Forecast: cbdMD, Inc.
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
CAPEX 1 | 1.199 | 1.32 | 0.342 | 0.6887 | 0.2975 | 0.19 |
Change | - | 10.13% | -74.09% | 101.36% | -56.79% | -36.14% |
Free Cash Flow (FCF) 1 | -9.188 | -5.318 | -7.479 | -9.38 | -0.6158 | 5.776 |
Change | - | 42.12% | -40.63% | -25.42% | 93.44% | 1,038.04% |
Announcement Date | 12/18/19 | 12/22/20 | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 |
1USD in Million
Estimates
Forecast Financial Ratios: cbdMD, Inc.
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | - | -40.26% | -41.81% | - | - | - | - | - |
EBIT Margin (%) | - | -41.98% | -44.1% | - | -22.88% | -8.17% | -3.7% | -3.5% |
EBT Margin (%) | - | 26.99% | -54.61% | - | -94.96% | -18.99% | -3.7% | -3.5% |
Net margin (%) | - | 29.21% | -58.34% | - | -111.53% | -39.54% | -12.97% | -3.5% |
FCF margin (%) | - | -28.61% | -32.45% | - | - | - | - | - |
FCF / Net Income (%) | - | -97.95% | 55.63% | - | - | - | - | - |
Profitability | ||||||||
ROA | -16.39% | -10.4% | -10.4% | -13.06% | -20.33% | -15.48% | - | - |
ROE | -176.01% | 21.67% | -25.66% | -104.16% | -113.4% | -67.31% | - | - |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | - | - | - | - | -0.25x | - | - | - |
Debt / Free cash flow | - | - | - | - | -3.06x | - | - | - |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | - | 3.15% | 0.77% | - | 1.23% | - | - | - |
CAPEX / EBITDA (%) | - | -7.83% | -1.84% | - | - | - | - | - |
CAPEX / FCF (%) | - | -11.02% | -2.37% | - | - | - | - | - |
Items per share | ||||||||
Cash flow per share 1 | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - |
Dividend per Share 1 | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - |
Book Value Per Share 1 | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - |
EPS 1 | - | 100.8 | -169.2 | -446.4 | -106.6 | -14.32 | -3.92 | -0.96 |
Change | - | - | -267.86% | -163.83% | 76.13% | 86.56% | 72.63% | 75.51% |
Nbr of stocks (in thousands) | - | 145 | 160 | 168 | 357 | 480 | 782.9 | 782.9 |
Announcement Date | - | 12/22/20 | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | - | - |
1USD
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | -0.24x | -0.99x |
PBR | - | - |
EV / Sales | 0.03x | 0.03x |
Yield | - | - |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.9500USD
Average target price
16.00USD
Spread / Average Target
+1,584.21%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- YCBD Stock
- Financials cbdMD, Inc.
Select your edition
All financial news and data tailored to specific country editions